Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2017

01-03-2017 | Original Article

Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience

Authors: Jacqueline G. O’Leary, Florence Wong, K. Rajender Reddy, Guadalupe Garcia-Tsao, Patrick S. Kamath, Scott W. Biggins, Michael B. Fallon, Ram M. Subramanian, B. Maliakkal, Leroy Thacker, Jasmohan S. Bajaj

Published in: Digestive Diseases and Sciences | Issue 3/2017

Login to get access

Abstract

Background

Women have lower serum creatinine values than men for similar renal function.

Aims

We aimed to determine the differential effect of baseline, peak, and delta creatinine between genders on outcomes in infected hospitalized cirrhotic patients.

Methods

North American Consortium for the Study of End-Stage Liver Disease is a 15-center consortium of tertiary care hepatology centers prospectively enrolling infected cirrhotic inpatients. Baseline, peak, and delta creatinine during hospitalization were compared between genders, and their impact on overall survival, transplant-free survival, probability of transplantation, and need for renal replacement therapy (RRT) was analyzed.

Results

In total, 532 patients with cirrhosis (males = 59% median admission MELD = 20) had significantly lower median baseline (1.07 vs. 1.30 mg/dL, p < 0.0001) and peak creatinine (1.47 vs. 1.59 mg/dL, p = 0.024) in women than men during hospitalization for an infection, but both genders had similar delta creatinine levels (0.30 vs. 0.30 mg/dL, p = 0.957). Thirty-day mortality was similar between genders. RRT was not used more often in women (19 vs. 12%, p = 0.050), and women were 1.8 times more likely than men to receive RRT at the same creatinine (p = 0.028). Both peak and delta creatinine significantly predicted 6-month overall and transplant-free survival (p < 0.0001), but the probability of liver transplantation was affected by the interaction between gender and both peak and delta creatinine.

Conclusions

Infected hospitalized cirrhotic women are significantly more likely than men to receive RRT at similar creatinine levels. Gender-specific differences in baseline, peak, and delta creatinine need further investigation to determine whether women need acute kidney injury treatment at lower creatinine thresholds than men.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jalan R, Yurdaydin C, Bajaj JS, et al. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology. 2014;147:4–10.CrossRefPubMed Jalan R, Yurdaydin C, Bajaj JS, et al. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology. 2014;147:4–10.CrossRefPubMed
2.
go back to reference Bajaj JS, O’Leary JG, Reddy KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology. 2014;60:250–256.CrossRefPubMedPubMedCentral Bajaj JS, O’Leary JG, Reddy KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology. 2014;60:250–256.CrossRefPubMedPubMedCentral
3.
go back to reference Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–1437. 37 e1–9.CrossRefPubMed Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–1437. 37 e1–9.CrossRefPubMed
4.
go back to reference Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61:1038–1047.CrossRefPubMed Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61:1038–1047.CrossRefPubMed
5.
go back to reference Wong F, Nadim MK, Kellum JA, et al. Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut. 2011;60:702–709.CrossRefPubMed Wong F, Nadim MK, Kellum JA, et al. Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut. 2011;60:702–709.CrossRefPubMed
6.
go back to reference Wong F, O’Leary JG, Reddy KR, et al. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology. 2013;145:1280e1–1288e1. Wong F, O’Leary JG, Reddy KR, et al. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology. 2013;145:1280e1–1288e1.
7.
go back to reference Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative w. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care. 2004;8:R204–R212.CrossRefPubMedPubMedCentral Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative w. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care. 2004;8:R204–R212.CrossRefPubMedPubMedCentral
8.
go back to reference Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.CrossRefPubMedPubMedCentral Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.CrossRefPubMedPubMedCentral
9.
go back to reference Ad hoc working group of E, Fliser D, Laville M, Covic A, Fouque D, Vanholder R, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27:4263–72. Ad hoc working group of E, Fliser D, Laville M, Covic A, Fouque D, Vanholder R, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27:4263–72.
10.
go back to reference Wong F, O’Leary JG, Reddy KR, et al. A cut-off serum creatinine value of 1.5 mg/dl for AKI—to be or not to be. J Hepatol. 2015;62:741–743.CrossRefPubMed Wong F, O’Leary JG, Reddy KR, et al. A cut-off serum creatinine value of 1.5 mg/dl for AKI—to be or not to be. J Hepatol. 2015;62:741–743.CrossRefPubMed
11.
go back to reference Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62:968–974.CrossRefPubMed Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62:968–974.CrossRefPubMed
12.
go back to reference Lai JC, Terrault NA, Vittinghoff E, Biggins SW. Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system. Am J Transplant. 2010;10:2658–2664.CrossRefPubMedPubMedCentral Lai JC, Terrault NA, Vittinghoff E, Biggins SW. Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system. Am J Transplant. 2010;10:2658–2664.CrossRefPubMedPubMedCentral
13.
go back to reference Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371–2378.CrossRefPubMedPubMedCentral Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371–2378.CrossRefPubMedPubMedCentral
14.
go back to reference Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores—a systematic bias. Am J Transplant. 2007;7:685–692.CrossRefPubMed Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores—a systematic bias. Am J Transplant. 2007;7:685–692.CrossRefPubMed
15.
go back to reference Huo SC, Huo TI, Lin HC, et al. Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation? Transplantation. 2007;84:1406–1412.CrossRefPubMed Huo SC, Huo TI, Lin HC, et al. Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation? Transplantation. 2007;84:1406–1412.CrossRefPubMed
16.
go back to reference Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 2011;54:462–470.CrossRefPubMed Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 2011;54:462–470.CrossRefPubMed
17.
go back to reference Mindikoglu AL, Regev A, Seliger SL, Magder LS. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transplant. 2010;16:1147–1157.CrossRef Mindikoglu AL, Regev A, Seliger SL, Magder LS. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transplant. 2010;16:1147–1157.CrossRef
18.
go back to reference Mariante-Neto G, Marroni CP, Fleck Junior AM, et al. Impact of creatinine values on MELD scores in male and female candidates for liver transplantation. Ann Hepatol. 2013;12:434–439.PubMed Mariante-Neto G, Marroni CP, Fleck Junior AM, et al. Impact of creatinine values on MELD scores in male and female candidates for liver transplantation. Ann Hepatol. 2013;12:434–439.PubMed
19.
go back to reference Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Racial and ethnic disparities in access to liver transplantation. Liver Transplant. 2010;16:1033–1040.CrossRef Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Racial and ethnic disparities in access to liver transplantation. Liver Transplant. 2010;16:1033–1040.CrossRef
20.
go back to reference Martin-Llahi M, Guevara M, Torre A, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology. 2011;140:488e4–496e4.CrossRef Martin-Llahi M, Guevara M, Torre A, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology. 2011;140:488e4–496e4.CrossRef
21.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.CrossRefPubMed Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.CrossRefPubMed
22.
go back to reference Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.CrossRefPubMed Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.CrossRefPubMed
23.
go back to reference Francoz C, Prie D, Abdelrazek W, et al. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transplant. 2010;16:1169–1177.CrossRef Francoz C, Prie D, Abdelrazek W, et al. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transplant. 2010;16:1169–1177.CrossRef
24.
go back to reference Wang HE, Jain G, Glassock RJ, Warnock DG. Comparison of absolute serum creatinine changes versus kidney disease: improving global outcomes consensus definitions for characterizing stages of acute kidney injury. Nephrol Dial Transplant. 2013;28:1447–1454.CrossRefPubMedPubMedCentral Wang HE, Jain G, Glassock RJ, Warnock DG. Comparison of absolute serum creatinine changes versus kidney disease: improving global outcomes consensus definitions for characterizing stages of acute kidney injury. Nephrol Dial Transplant. 2013;28:1447–1454.CrossRefPubMedPubMedCentral
25.
go back to reference Bajaj JS, O’Leary JG, Reddy KR, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology. 2012;56:2328–2335.CrossRefPubMedPubMedCentral Bajaj JS, O’Leary JG, Reddy KR, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology. 2012;56:2328–2335.CrossRefPubMedPubMedCentral
26.
go back to reference Bajaj JS, Reddy KR, Tandon P, et al. The three-month readmission rate remains unacceptably high in a large North American cohort of cirrhotic patients. Hepatology. 2015;64:200–208.CrossRef Bajaj JS, Reddy KR, Tandon P, et al. The three-month readmission rate remains unacceptably high in a large North American cohort of cirrhotic patients. Hepatology. 2015;64:200–208.CrossRef
Metadata
Title
Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience
Authors
Jacqueline G. O’Leary
Florence Wong
K. Rajender Reddy
Guadalupe Garcia-Tsao
Patrick S. Kamath
Scott W. Biggins
Michael B. Fallon
Ram M. Subramanian
B. Maliakkal
Leroy Thacker
Jasmohan S. Bajaj
Publication date
01-03-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4416-7

Other articles of this Issue 3/2017

Digestive Diseases and Sciences 3/2017 Go to the issue

UNM Clinical Case Conferences

Acute Pancreatitis: Nothing to SPiT At

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.